Peak6 Investments LLC Gilead Sciences, Inc. Call Options Transaction History

Peak6 Investments LLC

$43.5 Billion
Q3 2024

Call Options

22 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	SELL	$66.59 - $83.99 $18.1 Million - $22.8 Million	-271,400 Reduced 73.06%	100,100 $8.39 Million
Q2 2024 Aug 13, 2024	BUY	$63.15 - $72.88 $22.7 Million - $26.2 Million	360,100 Added 3158.77%	371,500 $25.5 Million
Q1 2024 May 14, 2024	BUY	$71.58 - $87.29 $100,212 - $122,206	1,400 Added 14.0%	11,400 $835,000
Q4 2023 Feb 13, 2024	BUY	$73.27 - $83.09 $732,700 - $830,900	10,000 New	10,000 $810,000
Q2 2023 Aug 11, 2023	SELL	$76.01 - $86.7 $3.01 Million - $3.43 Million	-39,600 Reduced 69.35%	17,500 $1.35 Million
Q1 2023 May 12, 2023	SELL	$77.31 - $88.08 $13 Million - $14.9 Million	-168,700 Reduced 74.71%	57,100 $4.74 Million
Q4 2022 Feb 10, 2023	SELL	$62.32 - $89.47 $34.6 Million - $49.6 Million	-554,400 Reduced 71.06%	225,800 $19.4 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $13.6 Million - $15.5 Million	228,300 Added 41.37%	780,200 $48.1 Million
Q2 2022 Aug 12, 2022	BUY	$57.72 - $65.01 $22 Million - $24.8 Million	381,700 Added 224.27%	551,900 $34.1 Million
Q1 2022 May 13, 2022	SELL	$57.92 - $72.58 $8.02 Million - $10.1 Million	-138,500 Reduced 44.87%	170,200 $10.1 Million
Q4 2021 Feb 11, 2022	SELL	$64.88 - $73.64 $6.36 Million - $7.22 Million	-98,000 Reduced 24.1%	308,700 $22.4 Million
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $3.18 Million - $3.43 Million	47,000 Added 13.07%	406,700 $28.4 Million
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $4.03 Million - $4.6 Million	71,200 Added 24.68%	359,700 $21 Million
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $8.11 Million - $10.2 Million	-130,600 Reduced 31.16%	288,500 $18.2 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $40 Million - $46.4 Million	-552,300 Reduced 56.86%	419,100 $32.2 Million
Q1 2020 May 14, 2020	BUY	$62.63 - $80.22 $55.5 Million - $71.1 Million	886,000 Added 1037.47%	971,400 $72.6 Million
Q4 2019 Feb 13, 2020	SELL	$61.62 - $67.78 $1.15 Million - $1.26 Million	-18,600 Reduced 17.88%	85,400 $5.55 Million
Q3 2019 Nov 08, 2019	SELL	$62.51 - $69.0 $7.69 Million - $8.49 Million	-123,000 Reduced 54.19%	104,000 $6.59 Million
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $8.09 Million - $9.07 Million	130,800 Added 135.97%	227,000 $15.3 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $1.69 Million - $1.9 Million	27,100 Added 39.22%	96,200 $6.25 Million
Q4 2018 Feb 13, 2019	SELL	$60.54 - $79.0 $653,832 - $853,200	-10,800 Reduced 13.52%	69,100 $4.32 Million
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $5.7 Million - $6.31 Million	79,900 New	79,900 $6.17 Million

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$10.9 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.4 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$6.9 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.57 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.43 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.

Account